PMGC HOLDINGS INC. Earnings Per Share (Basic)
PMGC HOLDINGS INC. (ELAB) reported Earnings Per Share (Basic) of -$0.07 per share for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2024-11-14
- PMGC HOLDINGS INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.60.
- PMGC HOLDINGS INC. earnings per share, basic for the quarter ending 2026-03-31 was -$11.17.
- PMGC HOLDINGS INC. earnings per share, basic for the quarter ending 2025-12-31 was $3.10, a 98.73% decline year-over-year.
- PMGC HOLDINGS INC. earnings per share, basic for the quarter ending 2025-09-30 was -$4.91.
- PMGC HOLDINGS INC. earnings per share, basic for fiscal 2023 was -$0.40.
- PMGC HOLDINGS INC. earnings per share, basic for fiscal 2022 was -$0.19.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.96 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$7.50 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$11.04 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2026-03-31 | -$11.17 derived: net income ÷ weighted average shares · filed 2026-05-15 | $30.72 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$2916.81 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$1731.96 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-12-31 | $3.10 derived: net income ÷ weighted average shares · filed 2026-03-30 | $25.72 derived: net income ÷ weighted average shares · filed 2026-03-30 | $43.97 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$380.69 derived: net income ÷ weighted average shares · filed 2026-03-30 |
| 2025-09-30 | -$4.91 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$11.62 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$13.70 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$49.46 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-06-30 | -$37.98 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$203.47 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$920.39 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1252.64 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-03-31 | -$248.03 derived: net income ÷ weighted average shares · filed 2026-05-15 | $4976.40 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$4884.88 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$1597.46 derived: net income ÷ weighted average shares · filed 2026-05-15 |
| 2024-12-31 | $244.62 derived: net income ÷ weighted average shares · filed 2026-03-30 | $2028.93 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$1502.16 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$6595.29 derived: net income ÷ weighted average shares · filed 2026-03-30 |
| 2024-09-30 | -$0.07 10-Q · filed 2024-11-14 | -$331.26 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$0.23 10-Q · filed 2024-11-14 | $0.74 derived: net income ÷ weighted average shares · filed 2025-11-14 |
| 2024-06-30 | -$0.08 10-Q · filed 2024-08-14 | -$0.16 10-Q · filed 2024-08-14 | $0.40 derived: net income ÷ weighted average shares · filed 2025-08-13 | $0.97 derived: net income ÷ weighted average shares · filed 2025-08-13 |
| 2024-03-31 | -$0.08 10-Q · filed 2024-05-15 | $0.17 derived: net income ÷ weighted average shares · filed 2025-05-14 | $0.51 derived: net income ÷ weighted average shares · filed 2025-05-14 | $1.91 derived: net income ÷ weighted average shares · filed 2025-05-14 |
| 2023-12-31 | $0.04 derived: net income ÷ weighted average shares · filed 2025-03-28 | $0.20 derived: net income ÷ weighted average shares · filed 2025-03-28 | $1.00 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$0.40 10-K · filed 2024-03-29 |
| 2023-09-30 | -$0.08 10-Q · filed 2024-11-14 | -$0.21 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.32 10-Q · filed 2024-11-14 | $116.47 derived: net income ÷ weighted average shares · filed 2024-11-14 |
| 2023-06-30 | -$0.13 10-Q · filed 2024-08-14 | -$0.24 10-Q · filed 2024-08-14 | $117.40 derived: net income ÷ weighted average shares · filed 2024-08-14 | $66.52 derived: net income ÷ weighted average shares · filed 2024-08-14 |
| 2023-03-31 | -$0.11 10-Q · filed 2024-05-15 | $118.98 derived: net income ÷ weighted average shares · filed 2024-05-15 | $67.33 derived: net income ÷ weighted average shares · filed 2024-05-15 | |
| 2022-12-31 | $120.17 derived: net income ÷ weighted average shares · filed 2024-03-29 | $67.86 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$0.19 10-K · filed 2024-03-29 | |
| 2022-09-30 | -$0.05 10-Q · filed 2023-12-11 | -$0.12 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |